12.07.2015 Views

Conference Program - ABRF 2011 - Association of Biomolecular ...

Conference Program - ABRF 2011 - Association of Biomolecular ...

Conference Program - ABRF 2011 - Association of Biomolecular ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

kits for Tempus TM and PAXgene® stabilized blood. Isolated total RNAwas then processed through the GLOBINclear TM -Human kit and thenamplified with the MessageAmp TM Premier kit creating a library forhybridization to the Affymetrix Human U133A 2.0 expression arrays.Affymetrix GeneChip® microarray analysis showed parameters withinnormal limits for expressed genes. Reported results<strong>of</strong> this controlledexperiment, support a validated gene expression workflow for bloodon Affymetrix expression arrays using a combination <strong>of</strong> commercial kitsfor RNA purification from stabilized blood and library amplificationoptimized for hybridization and analysis on expression microarrays.159 Performance Comparison <strong>of</strong> FourMethods Utilized for the Purification<strong>of</strong> Enzymatically-Digested,Fluorescently-Labeled PCR FragmentsGenerated During T-RFLP AnalysisM. Zianni, J. Panescu, P. KumarThe Ohio State University, Columbus, OH, UnitedStatesThe fluorescently-labeled Terminal Restriction Fragment LengthPolymorphism (T-RFLP) assay based on amplified ribosomal DNAfrom bacteria is an inexpensive, widely accessible, effective and wellestablishedmolecular technique for the identification and comparativequantification <strong>of</strong> bacterial species in metagenomics. In order t<strong>of</strong>acilitate the detection <strong>of</strong> a large proportion <strong>of</strong> species in a givensample, it is necessary to maximize the recovery <strong>of</strong> the fluorescentlylabeled,restriction enzyme-digested PCR fragments generatedduring the process. The post-digestion purification method used t<strong>of</strong>acilitate fragment separation is a critical step in the retention <strong>of</strong> DNAfragments. Four methods for post-digestion purification were testedin an effort to characterize their integrity, effectiveness, ease <strong>of</strong> useand potential biases: solid phase reversible immobilization (AMPure TMand CleanSEQ TM ), contaminant capture (BigDye® XTerminator TM ),and dialysis (Millipore TM Nitrocellulose Membranes). Samples werecollected from four different oral sites in each <strong>of</strong> 16 patients. Eachsample was divided equally and the DNA was isolated with two distinctmethods. PCR reactions were carried out with two paired universalprimers for the 16S gene that were labeled with VIC and FAM, purifiedwith AMPure TM and digested separately with HhaI and MspI restrictionenzymes. From each <strong>of</strong> the digestions, identical aliquots were purifiedwith the four different methods. The DNA fragments were analyzedon the Applied BioSystems TM 3730 DNA Analyzer using identicalconditions, followed by data analysis with GeneMapper® v4.0. Basedon preliminary data analysis, CleanSEQ TM is the superior purificationmethod because it resulted in the most numerous peaks recovered persample with a wide distribution <strong>of</strong> sizes from approximately 50 to 1200bp.160 Electrochemical Simulation<strong>of</strong> Covalent DNA AdductFormation Monitored with LiquidChromatography/Mass SpectrometryJ. Powers 2 , S. Plattner 1 , R. Erb 1 , F. Pitterl 1 ,J.P. Chervet 2 , H. Oberacher 11Institute <strong>of</strong> Legal Medicine, Innsbruck MedicalUniversity, Innsbruck, Austria; 2 Antec, Palm Bay, FL,United StatesDNA adduct is a piece <strong>of</strong> DNA covalently bond to chemicals. Adductsactivate repair processes and, unless repaired prior to replication, maylead to nucleotide substitutions, deletions, and other rearrangements.As alterations <strong>of</strong> the genetic material can cause severe diseasesincluding cancer, inflammation, and neurodegenerative disorders,tests on mutagenicity/genotoxicity have become an integral part <strong>of</strong> riskassessment during the development <strong>of</strong> any new chemical. A number <strong>of</strong> invitro tests using different cell lines and in vivo tests mainly using rodentsare available to identify hazardous compounds. The majority <strong>of</strong> thesetests are time-consuming, labor-intensive and hardly automatable. So insearch for alternative methods, the usefulness <strong>of</strong> electrochemistry (EC)-liquid chromatography (LC)-mass spectrometry (MS) was evaluated.Generally, EC represents a powerful tool to study in vitro biologicaloxidation processes <strong>of</strong> a number <strong>of</strong> different compounds, includingdrugs, peptides and proteins. Here, we used EC to initiate adductformation. The obtained reaction products were separated by LC anddetected by MS. Tandem MS experiments were used for structuralconfirmation. In a pro<strong>of</strong> <strong>of</strong> principle study acetaminophen was selectedas model compound. Covalent adduct formation was observed forelectrochemical activated mixtures <strong>of</strong> acetaminophen and guanosine.Mechanistic studies revealed that adduct formation will only start atelectrochemical potentials sufficiently high to initiate oxidation <strong>of</strong> bothacetaminophen and guanosine. The stringent necessity <strong>of</strong> coactivationsheds a new light on the mechanism <strong>of</strong> adduct formation, becauseaccording to the generally accepted theory activation <strong>of</strong> the adductformingagent should be sufficient. Chromatographic separationenabled the differentiation <strong>of</strong> four isomeric forms. Their connection toacetaminophen was proven in dose-response experiments. EC/LC/MSrepresents a fast, simple, convenient and functional tool to study DNAadduct formation which has great potential to complement the existingbattery <strong>of</strong> mutagenicity/genotoxicity tests.**161 Quantitative miRNA ExpressionAnalysis Using Fluidigm Micr<strong>of</strong>luidicsDynamic ArraysJ. Jen, J. Sung Jang, V.A. Simon, R.M. Feddersen,F. Rakhshan, D.A. Schultz, M.A. Zschunke,W.L. Lingle, C.P. Kolbert.Mayo Clinic Micorarray Shared Resource andBiospecimens Accessioning Processing SharedResource, Rochester, MN, United StatesPoster AbstractsMicroRNA (miRNA) is a small non-coding RNA that can regulate geneexpression in both plants and animals. Studies showed that miRNAs playa critical role in human cancer by targeting messenger RNAs that arepositive or negative regulators <strong>of</strong> cell proliferation and apoptosis. Here,we evaluated miRNA expression in formalin fixed, paraffin embedded(FFPE) samples and fresh frozen (FF) samples using a high throughputqPCR-based micr<strong>of</strong>luidic dynamic array technology (Fluidigm). Wecompared the results to hybridization-based microarray platforms<strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine • 77

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!